Workflow
Seasonally record-high volumes and revenues for Mowi in Q2
Globenewswire· 2025-08-20 04:30
Core Insights - Mowi achieved record-high operating revenues of EUR 1.39 billion in Q2 2025, resulting in an operational profit of EUR 189 million, driven by strong biological and operational performance, high volumes, and decreasing costs [1][2][5] Financial Performance - The company harvested a record 133,000 tonnes in Q2 2025, marking a 21% increase compared to the previous year, and has raised its volume guidance for 2025 to 545,000 tonnes, reflecting a 9% annual growth from 2024 [2][3] - Mowi's production costs fell to the lowest level since 2022 in Q2, contributing EUR 49 million to earnings for the quarter and EUR 67 million for the first half of 2025, attributed to lower feed prices and cost-cutting measures [5] - Mowi Consumer Products reported its best quarter yet, benefiting from high volumes and lower raw material prices, while Mowi Feed also achieved record-high earnings and sold volumes for a second quarter [6][8] Growth Strategy - Mowi plans to increase its ownership stake in Nova Sea from 49% to 95%, expecting to harvest at least 600,000 tonnes by 2026, which represents a 10% growth [3] - The company has transitioned from producing 400,000 tonnes per year globally to a projected 600,000 tonnes in 2026, achieving an annual growth rate of 6.1%, surpassing the industry average of 3.3% [4] Market Dynamics - Total salmon consumption value increased by 5% compared to the same period in 2024, with global supply growth reaching 18% in Q2 2025, although prices are under pressure due to this supply increase [9] - The market anticipates only marginal supply growth in 2026, which is expected to lead to higher salmon prices [9] Dividend Announcement - Mowi's Board of Directors has declared a quarterly dividend of NOK 1.45 per share [10]
Lerøy Seafood Group ASA: Solid operations across all segments, strong earnings in VAP S&D and Wild Catch
Globenewswire· 2025-08-20 04:30
"We delivered solid operations across all segments in the second quarter, resulting in an operational EBIT of NOK 680 million in the quarter. The quarter clearly illustrates the robustness of our business model with a fully integrated value chain in a diversified seafood company," says CEO of Lerøy Seafood Group ASA (LSG), Henning Beltestad. FARMING – STRONG BIOLOGICAL PERFORMANCE BUT LOW PRICES FOR SALMON AND TROUT. Operational EBIT in the second quarter of 2025 ended at NOK 256 million in the Farming segm ...
Nokia and Netplus deliver advanced IPTV services for enhanced customer experience in India
GlobeNewswire News Room· 2025-08-20 04:30
Press ReleaseNokia and Netplus deliver advanced IPTV services for enhanced customer experience in India Nokia deploys the latest 400G routing technology and software-defined access network (SDAN) platform to scale high-speed broadband and IPTV services for Netplus across Punjab and other cities.Nokia deployment delivers improved customer experience, better energy efficiency and flexibility to support evolving needs in business and education. 20 August 2025 New Delhi, India – Nokia today announced that Netp ...
Dax Index News: Peace Hopes Lift Outlook, But Fed Policy Clouds Forecast Today
FX Empire· 2025-08-20 04:00
Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading activities [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].
Sumitomo Corporation Invests in Ursa Space to Accelerate Global Growth and Expand into Japan
Prnewswire· 2025-08-20 04:00
Core Insights - Ursa Space Systems has received a strategic investment from Sumitomo Corporation of Americas, enhancing its expansion into the Japanese market and overall capabilities [1][3][5] - The partnership aims to leverage Ursa Space's geospatial AI solutions to provide rapid and scalable insights to a broader audience, particularly in Asia [2][3][5] Company Overview - Ursa Space Systems specializes in satellite-based analytic solutions, utilizing a comprehensive virtual constellation of commercial Earth observation data [2][6] - The company offers subscription and custom monitoring services that enable real-time detection of changes in the physical world, overcoming traditional limitations [4][5] Investment Impact - The new funding will allow Ursa Space to grow its capabilities and enhance its platform, shifting from image-first to indicator-first analysis, thus improving user experience and efficiency [5] - Sumitomo Corporation joins existing investors, including Dorilton Capital and RRE Ventures, indicating strong confidence in Ursa Space's potential [5] Strategic Goals - The partnership with Sumitomo is expected to accelerate Ursa Space's mission to deliver insights at unmatched speed and scale, particularly targeting the Japanese market [3][5] - Ursa Space aims to provide actionable information across various industries, including finance and energy, by integrating satellite data into customer workflows [6]
TOWNGAS SMART ENERGY(1083.HK):MAINTAIN BUY ALTHOUGH RENEWABLES SEE LOWER POWER TARIFF
Ge Long Hui· 2025-08-20 03:48
Core Viewpoint - Towngas Smart Energy (TGSE) reported a 2% year-on-year growth in earnings to HK$758 million in 1H25, which was 2% below expectations. The company anticipates a 32% increase in earnings in 2H25, driven by higher profits from its renewable business [1][5]. Financial Performance - The profit after tax from the natural gas business increased by 6% year-on-year to HK$527 million, with flat gas sales volume as residential growth was offset by a decline in commercial sales. The dollar margin improved from RMB0.56/m³ in 1H24 to RMB0.57/m³ in 1H25 [1]. - New connections decreased by 16% year-on-year to 0.38 million households in 1H25, leading to a 30% drop in profit after tax for this segment to HK$219 million, with profit margin contracting from 38.5% in 1H24 to 35.1% in 1H25 [2]. - The renewable business's net profit grew by only 5% year-on-year to HK$172 million in 1H25 [2]. Renewable Energy Projects - TGSE launched new distributed photovoltaic (PV) projects with a total capacity of 280 MW, resulting in a 44% year-on-year increase in total power generation. However, the unit gross profit decreased by RMB0.04/kWh due to lower power tariffs, leading to an 11% year-on-year increase in operating profit from PV power generation to RMB169 million [3]. Restructuring and Gains - The gain from the disposal of partial stakes in distributed PV projects fell by 15% year-on-year to RMB37 million in 1H25, as only stakes in 120 MW projects were disposed of. Profit from energy and carbon management also decreased by 13% year-on-year to RMB25 million due to a high base in power trading last year [4]. - The restructuring of TGSE's extended business was completed in 1H25, resulting in a HK$100 million gain from the restructuring, with the company now holding only 12% of a joint venture majority-owned by its parent [4]. Future Outlook - The company expects earnings to surge by 32% in 2H25, primarily due to higher profits from the renewable business, as approximately 63% of the renewable business's profit in 2024 was generated in 2H24 [5]. - The target price has been reduced from HK$4.99 to HK$4.77, reflecting cuts in earnings forecasts, with the new target price equating to 9.6 times the estimated P/E for 2025 [5].
Caesars Entertainment Is Getting Closer To A Buy
Seeking Alpha· 2025-08-20 03:42
Core Insights - The author has been contributing to investment websites since 2011, focusing on value investing rather than growth investing [1] - The author has a background in finance, having obtained Series 7 and 63 licenses in 1999, and has witnessed significant market events such as the dot-com bubble [1] Company and Industry Summary - There is no specific company or industry analysis provided in the documents [2][3]
Grupo Financiero Galicia: Buy The Dip To Play Argentina's Recovery
Seeking Alpha· 2025-08-20 03:19
Group 1 - The article discusses the potential for a second chance to invest in Argentine stocks following a recent market pullback and the election of Milei, which has initiated a stabilization plan aimed at reducing inflation to single-digit levels [1] - The focus is on identifying undervalued stocks in the Latin American region, particularly in sectors such as technology, retail, and banking [1] - The investment approach emphasized is a combination of rigorous bottom-up analysis and macro-driven opportunities to uncover long-term value [1]
Ames National: Appealing Yield But Risky Income Play, Hold
Seeking Alpha· 2025-08-20 03:18
Core Insights - The article discusses the expertise of Labutes IR as a Fund Manager/Analyst in the financial sector, highlighting over 18 years of experience in financial markets [1] Group 1 - Labutes IR specializes in the financial sector and has extensive experience in portfolio management [1] - The author has worked at various institutions on the buy side, indicating a strong background in investment strategies [1]
HANSOH PHARMACEUTICAL(3692.HK):1H25 RESULTS BEAT;TP UP ON PROVEN BD CAPABILITY
Ge Long Hui· 2025-08-20 03:09
Core Insights - Hansoh Pharma reported strong 1H25 results, with revenue and net profit increasing by 14.3% and 15.0% YoY, respectively, driven by a 24% YoY growth in core innovative drug sales and continued collaboration revenue [1][2] - Management raised its 2025 revenue guidance to high-double-digit growth, forecasting at least RMB10 billion from innovative drugs, with Ameile expected to contribute RMB6 billion [1][4] Financial Performance - 1H25 revenue reached RMB7.4 billion, while net profit was RMB3.1 billion, exceeding market expectations [2] - Innovative drug sales accounted for RMB4.5 billion, representing a 24% YoY growth and 78% of total drug sales, while generic drug sales fell 13% YoY to RMB1.3 billion [3] - Gross margin remained stable at 91.1%, and R&D expenses increased by 20% YoY to RMB1.4 billion, accounting for 19% of total revenue [3] Future Guidance - Management anticipates generic drug sales of RMB2.5 billion for 2025, gradually declining to RMB2 billion in the long term [5] - Key assets like B7H3/B7H4 ADCs and GLP-1 candidates are expected to advance in global trials in late 2025 and 2026 [1][5] Key Assets and Development - Ameile is projected to generate RMB6 billion in sales, with a peak sales target of RMB8 billion, and is undergoing pivotal trials for new indications [5] - Key timelines for other projects include Phase III trial initiation for HS-20093 and HS-20089 expected in 4Q25 and 2026, respectively [5] Valuation and Target Price - Following the results, the company adjusted drug sales forecasts for 2025-27 and incorporated an upfront payment from Regeneron of US$80 million [6] - The 12-month target price is set at HK$41.3, maintaining a BUY rating based on the potential for recurring business development revenue [6][7]